Knockdown of SRSF3 expression significantly inhibits VEGF (vascular endothelial growth factor) expression in colorectal cancer cells, cancer cell migration, and tube formation by human umbilical vein endothelial cells (HUVECs) in vitro via a proangiogenic SRF (serum response factor) gene. This evidence concerns the gene SRSF3 and cancer.